Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse

Insights

Proto-oncogenes int-1 and int-2 are activated in mammary tumors. Researchers investigated their normal expression patterns in developing mice, finding distinct temporal and spatial activity during embryogenesis and in adult tissues.

Area of Science:

  • Developmental Biology
  • Oncogenesis
  • Molecular Biology

Background:

  • The int-1 and int-2 genes were identified as proto-oncogenes activated by mouse mammary tumor virus (MMTV) proviral insertions in mammary carcinomas.
  • Previous studies indicated these genes were not expressed in normal adult mouse tissues, suggesting a role in development or specific cell types.

Purpose of the Study:

  • To investigate the expression patterns of int-1 and int-2 proto-oncogenes during mouse embryogenesis.
  • To determine if int-1 and int-2 are expressed in cultured teratocarcinoma cells.

Main Methods:

  • Analysis of int-1 and int-2 RNA expression in mouse embryos at various developmental stages (peri-implantation, mid-gestation, late gestation).
  • Examination of RNA from cultured teratocarcinoma cells.
  • Detection of RNA in normal adult mouse tissues and postpuberal testes.

Main Results:

  • Int-1 RNA was detected specifically during mid-gestation (days 8-13) and in adult testes.
  • Four species of int-2 RNA were found in peri-implantation embryos and teratocarcinoma cells, with high abundance in primitive endodermal lineage derivatives.
  • Int-2 RNA was not detected during mid- or late gestation or in any tested normal adult tissues.

Conclusions:

  • The proto-oncogenes int-1 and int-2 exhibit distinct temporal and spatial expression patterns during mouse development and in adult tissues.
  • These findings highlight differential gene regulation of proto-oncogenes activated by similar mechanisms in carcinogenesis.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...